Tetrahydrofolic acid is a folic acid derivative.It is a coenzyme in many reactions, especially in the metabolism of amino acids and nucleic acids. It acts as a donor of a group with one carbon atom. It gets this carbon atom by sequestering formaldehyde produced in other processes. A shortage in THF can cause megaloblastic anemia.
Tetrahydrofolic acid is reduced by the drug methotrexate, which is used to impair nucleotide synthesis. This drug is a potent chemotherapy and anti rheumatic.
Tetrahydrofolic acid is involved in the conversion of formiminoglutamic acid to glutamic acid; this may reduce the amount of histidine available for decarboxylation and protein synthesis, and hence the urinary histamine and formiminoglutamic acid may be decreased.
Organism species: Pan-species (General)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | CPG411Ge11 | BSA Conjugated Tetrahydrofolic Acid (THFA) | Immunogen; SDS-PAGE; WB. |
CPG411Ge21 | OVA Conjugated Tetrahydrofolic Acid (THFA) | Immunogen; SDS-PAGE; WB. | |
Antibodies | PAG411Ge01 | Polyclonal Antibody to Tetrahydrofolic Acid (THFA) | ELISA, CLIA. / IHC-Fr, ICC, IP (predicted). |
Assay Kits | CEG411Ge | ELISA Kit for Tetrahydrofolic Acid (THFA) | Enzyme-linked immunosorbent assay for Antigen Detection. |